Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365477 · ClinicalTrials.gov registry record · Phase 4
Empiric Versus Selective Prevention Strategies for Kidney Stone Disease
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT05365477 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 56 participants.
The verdict
NCT05365477, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.
Interventions
- BEHAVIORAL Empiric Therapy: Diet
- DRUG Empiric Therapy: Drug
- BEHAVIORAL Selective Therapy: Diet
- DRUG Selective Therapy: Drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2026-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05365477
The ClinicalTrials.gov registry entry for NCT05365477 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Empiric Therapy: Diet is the first listed.
NCT05365477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05365477 about?
NCT05365477 is a clinical study titled "Empiric Versus Selective Prevention Strategies for Kidney Stone Disease". The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.
What is the current status of trial NCT05365477?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2022-08-04. Estimated completion is 2026-03-31.
What interventions are being tested in trial NCT05365477?
The interventions under investigation include: Empiric Therapy: Diet (BEHAVIORAL), Empiric Therapy: Drug (DRUG), Selective Therapy: Diet (BEHAVIORAL), Selective Therapy: Drug (DRUG).
Who is sponsoring clinical trial NCT05365477?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.